GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
GH Research Announces Publication of Phase 2b Results for Mebufotenin in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
Finlay Minerals Ltd. engages German Mining Networks and renews engagement with Investing News Network
